Pricing Log in Create free account

CytoMed Therapeutics Limited (GDTC) vs Palatin Technologies, Inc. (PTN)

CytoMed Therapeutics Limited and Palatin Technologies, Inc. are both Biotechnology companies. CytoMed Therapeutics Limited and Palatin Technologies, Inc. are of similar size ($10.4M and $10.2M). CytoMed Therapeutics Limited has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 12.2×. CytoMed Therapeutics Limited has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, CytoMed Therapeutics Limited leads on 7 and Palatin Technologies, Inc. on 5.

Valuation

Metric GDTC PTN Biotechnology median
P/E n/m 12.21 10.26
P/S n/m 1.23 9.18
P/B 0.55 2.43 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 0.67 8.98
Earnings yield (32.94%) 8.19% (34.89%)
Free cash flow yield (0.40%) (83.75%) (24.52%)

Profitability

Metric GDTC PTN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin — (65.74%) 0.00%
Net margin 0.00% (63.54%) 0.00%
Free cash flow margin 0.00% (103.07%) 0.00%
Return on equity 0.00% (877.60%) (50.12%)
Return on assets 0.00% (142.11%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GDTC PTN Biotechnology median
Revenue growth (TTM) — 110.89% 6.26%
EPS growth (last fiscal year) (68.75%) 90.80% 29.88%
Revenue growth, 5-year CAGR — 156.83% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GDTC PTN Biotechnology median
Debt to equity 80.30 0.00 0.00
Current ratio 2.64 4.61 4.89
Net debt to EBITDA 0.86 0.87 1.01

Dividend

Metric GDTC PTN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GDTC PTN Biotechnology median
Market cap 10.41m 10.17m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack